Related Articles
<em>In vitro</em> assessment of the efficiency of the PIM‑1 kinase pharmacological inhibitor as a potential treatment for Burkitt's lymphoma
Methylation and decreased expression of SHP-1 are related to disease progression in chronic myelogenous leukemia
Gemcitabine and cisplatin-induced tumor lysis syndrome in a patient with gallbladder carcinoma: A case report
Tumor lysis syndrome in a patient with advanced lung squamous cell carcinoma undergoing combined therapy with a programmed cell death protein 1 inhibitor and first‑line chemotherapy: A case report
ND‑09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR‑ABL signaling Corrigendum in /10.3892/or.2023.8518